McKesson Corporation (LON:0JZU)
London
· Delayed Price · Currency is GBP · Price in USD 810.45
-0.14 (-0.02%)
At close: Dec 5, 2025
McKesson Revenue
McKesson had revenue of $103.15B USD in the quarter ending September 30, 2025, with 10.14% growth. This brings the company's revenue in the last twelve months to $387.09B, up 17.23% year-over-year. In the fiscal year ending March 31, 2025, McKesson had annual revenue of $359.05B with 16.22% growth.
Revenue (ttm)
$387.09B
Revenue Growth
+17.23%
P/S Ratio
0.26
Revenue / Employee
$8.60M
Employees
45,000
Market Cap
74.91B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 359.05B | 50.10B | 16.22% |
| Mar 31, 2024 | 308.95B | 32.24B | 11.65% |
| Mar 31, 2023 | 276.71B | 12.75B | 4.83% |
| Mar 31, 2022 | 263.97B | 25.74B | 10.80% |
| Mar 31, 2021 | 238.23B | 7.18B | 3.11% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Convatec Group | 1.72B |
| Hikma Pharmaceuticals | 2.35B |
| HUTCHMED (China) | 439.54M |
| Genus | 672.80M |
McKesson News
- 1 day ago - If You Invested $1000 In McKesson Stock 5 Years Ago, You Would Have This Much Today - Benzinga
- 1 day ago - McKesson Corp at Evercore ISI Healthcare Conference Transcript - GuruFocus
- 1 day ago - McKesson Corporation (MCK) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha
- 1 day ago - Guru Fundamental Report for MCK - Nasdaq
- 4 days ago - Noteworthy ETF Outflows: USMV, MCK, COR, WM - Nasdaq
- 5 days ago - McKesson's Advancing Community Oncology Report Charts a New Era of Innovation for Biopharma and Community Care - Business Wire
- 10 days ago - Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now? - Nasdaq
- 12 days ago - 3 Reasons Growth Investors Will Love McKesson (MCK) - Nasdaq